Dthera Sciences (OTCPK:DTHR) announced that it has entered into a promissory note purchase agreement for private placement of 1 senior secured convertible promissory note at a price of $250,00 per note for gross proceeds of $250,000 with Wade Capital Corporation on September 14, 2018. The company will issue warrants to purchase 500,000 shares of the company at an exercise price of $0.65 per share for a term of 5 years. The company with also issue 250,000 restricted commitment shares within 5 days of closing of the transaction. The note has a face value of $275,000 and is issued at discount of 10%. The note carries a fixed coupon of 10% per annum and would mature on September 14, 2019. The company issued securities pursuant to exemption provided under Regulation D.